Data Infrastructure OZMOSI positions itself as the data infrastructure layer for pharma R&D, turning fragmented trial and pipeline data into standardized, AI-ready datasets. This creates a strong cross-sell opportunity for customers seeking end-to-end data management, integration, and analytics capabilities to support decision-making.

AI Enabled Decisions Their value proposition emphasizes eliminating manual data cleaning to enable faster, clearer decision support. This aligns with sales opportunities around AI-driven portfolio analysis, scenario planning, and competitive intelligence for pharmaceutical and biotech firms facing high uncertainty.

Strategic Partnerships Recent integration with Planview signals a pathway for expanding reach through existing Planview customers who need real-world clinical and market signals embedded into portfolio management, representing a ready-made upsell to portfolio and pipeline decision-makers.

Growing Financials With reported revenue between ten and twenty-five million and a lean team, there is potential for scalable services or productized offerings, along with targeted expansions into larger pharma and biotech accounts seeking data standardization and rapid insights.

Industry Focus Specialization in pharmaceutical and biotechnology R&D data and competitive intelligence creates a defensible market position. This focus can be leveraged to target pharma and biotech companies undergoing digital modernization, data governance initiatives, or AI-readiness programs.